doi:10.19982/j.issn.1000-6621.20240561

Abstract

CLC Number:

Figures/Tables 6

References 24

[1]	Dian S, Ganiem AR, van Laarhoven A. Central nervous system tuberculosis. Curr Opin Neurol, 2021, 34(3):396-402. doi:10.1097/WCO.0000000000000920. pmid: 33661159
[2]	Streptomycin in Tuberculosis Trials Commitee, Medical Research Council. Streptomycin treatment of tuberculous meningitis. Lancet, 1948, 251(6503): 582-596. doi:10.1016/S0140-6736(48)92003-0.
[3]	中华医学会结核病学分会结核性脑膜炎专业委员会. 2019中国中枢神经系统结核病诊疗指南. 中华传染病杂志, 2020, 38(7):400-408. doi:10.3760/cma.j.cn311365-20200606-00645.
[4]	Rock RB, Olin M, Baker CA, et al. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev, 2008, 21(2):243-261, table of contents. doi:10.1128/CMR.00042-07. pmid: 18400795
[5]	Navarro-Flores A, Fernandez-Chinguel JE, Pacheco-Barrios N, et al. Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta-analysis. J Neurol, 2022, 269(7):3482-3494. doi:10.1007/s00415-022-11052-8. pmid: 35288778
[6]	Singh AK, Malhotra HS, Garg RK, et al. Paradoxical reaction in tuberculous meningitis: presentation, predictors and impact on prognosis. BMC Infect Dis, 2016, 16:306. doi:10.1186/s12879-016-1625-9. pmid: 27329253
[7]	Tai MS, Nor HM, Kadir KAA, et al. Paradoxical Manifestation is Common in HIV-negative Tuberculous Meningitis. Medicine (Baltimore), 2016, 95(1):e1997. doi:10.1097/MD.0000000000001997.
[8]	Barnacle JR, Davis AG, Wilkinson RJ. Recent advances in understanding the human host immune response in tuberculous meningitis. Front Immunol, 2024, 14: 1326651. doi:10.3389/fimmu.2023.1326651.
[9]	Thuong NTT, Thwaites GE. Treatment-Associated Inflammatory Deterioration in Tuberculous Meningitis: Unpicking the Paradox. J Infect Diseases, 2017, 215(5):665-667. doi:10.1093/infdis/jiw565.
[10]	Jha SK, Garg RK, Jain A, et al. Definite (microbiologically confirmed) tuberculous meningitis: predictors and prognostic impact. Infection, 2015, 43(6):639-645. doi:10.1007/s15010-015-0756-z. pmid: 25724799
[11]	Bahr NC, Boulware DR. Methods of rapid diagnosis for the etiology of meningitis in adults. Biomark Med, 2014, 8(9):1085-1103. doi:10.2217/bmm.14.67. pmid: 25402579
[12]	Teoh R, O’Mahony G, Yeung VT. Polymorphonuclear pleocytosis in the cerebrospinal fluid during chemotherapy for tuberculous meningitis. J Neurol, 1986, 233(4):237-241. doi:10.1007/BF00314027. pmid: 3746363
[13]	Sütlaş PN, Unal A, Forta H, et al. Tuberculous meningitis in adults: review of 61 cases. Infection, 2003, 31(6):387-391. doi:10.1007/s15010-003-3179-1. pmid: 14735380
[14]	Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med, 2004, 351(17):1741-1751. doi:10.1056/NEJMoa040573.
[15]	中国人民解放军总医院第八医学中心结核病医学部/全军结核病研究所/全军结核病防治重点实验室/结核病诊疗新技术北京市重点实验室, 《中国防痨杂志》编辑委员会. 糖皮质激素在结核病治疗中的合理应用专家共识. 中国防痨杂志, 2022, 44(1):28-37. doi:10.19982/j.issn.1000-6621.20210683.
[16]	Schoeman JF, Springer P, van Rensburg AJ, et al. Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study. J Child Neurol, 2004, 19(4):250-257. doi:10.1177/088307380401900402. pmid: 15163089
[17]	Keddie S, Bharambe V, Jayakumar A, et al. Clinical perspectives into the use of thalidomide for central nervous system tuberculosis. Eur J Neurol, 2018, 25(11):1345-1351. doi:10.1111/ene.13732. pmid: 29935038
[18]	Tsenova L, Mangaliso B, Muller G, et al. Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis. Antimicrob Agents Chemother, 2002, 46(6):1887-1895. doi:10.1128/AAC.46.6.1887-1895.2002.
[19]	黄永锋. 中枢神经系统感染性疾病患者脑脊液细胞因子变化情况研究. 陕西医学杂志, 2016, 45(7):850-852. doi:10.3969/j.issn.1000-7377.2016.07.32.
[20]	Ginalis EE, Fernández LL, Ávila JP, et al. A review of external lumbar drainage for the management of intracranial hypertension in traumatic brain injury. Neurochirurgie, 2022, 68(2):206-211. doi:10.1016/j.neuchi.2021.05.004.
[21]	陈宇, 樊丽超, 陈禹, 等. 持续腰大池引流术在结核性脑膜炎治疗中的应用. 结核病与肺部健康杂志, 2018, 7(3):221-224. doi:10.3969/j.issn.2095-3755.2018.03.016.
[22]	孟艺哲, 韩玮欣, 李军霞, 等. 腰大池置管持续引流治疗重症结核性脑膜炎临床分析. 结核与肺部疾病杂志, 2022, 3(6):496-500. doi:10.19983/j.issn.2096-8493.20220041.
[23]	李伟, 王勇. 腰大池置管引流在结核性脑膜炎治疗中的应用效果. 中国继续医学教育, 2019, 11(4):92-94. doi:10.3969/j.issn.1674-9308.2019.04.042.
[24]	Berning SE, Cherry TA, Iseman MD, et al. Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report. Clin Infect Dis, 2001, 32(4):643-646. doi:10.1086/318698. pmid: 11181130

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 6

References 24

Related Articles 14

Recommended Articles

Metrics

Comments

[1]	Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481.
[2]	Wang Chenyuan, Wang Shanshan, Wang Sainan, Shao Ge, Cao Jiayi, Xiong Haiyan, Hu Yi. Evaluation of the effectiveness of cerebrospinal fluid characteristics indicators in assisting rapid screening of tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2024, 46(3): 311-317.
[3]	Shi Jiayun, Zhou Haiyi, Wei Songqing, Jiang Jie, Wu Lei. Analysis of clinical features and influencing factors of epilepsy secondary to tuberculosis meningitis in children [J]. Chinese Journal of Antituberculosis, 2023, 45(11): 1090-1096.
[4]	Shi Yuting, Dong Jing, Jia Hongyan, Zhu Chuanzhi, Yang Bin, Li Zihui, Sun Qi, Du Boping, Xing Aiying, Zhang Zongde, Pan Liping. The role of miR-99a-5p in the immune regulation of host macrophages infected by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(5): 464-471.
[5]	Li Xiang, Qi Min, Jiang Jianjie, Wei Jialu, Fu Xuwen, Li Haiwen, Zhang Le. Analysis of risk factors for acute cerebral infarction combined with intracranial tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(5): 499-506.
[6]	Shi Jiayun, Wang Manzhi, Zhou Haiyi, Zhang Xiaofo, Wei Songqing. Dynamic changes and significance of biomarkers of cerebral injury in pediatric tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2022, 44(12): 1338-1344.
[7]	Chen Qifu, Zhang Shengkun, Liao Guangsheng, Tang Zhong, Zhan Shenlin, Deng Guofang, Zhang Peize, Chu Ming. Clinical effect on the treatment of long tunnelled external ventricular drainage for tuberculous meningitis complicated with hydrocephalus [J]. Chinese Journal of Antituberculosis, 2022, 44(11): 1187-1192.
[8]	CHEN Meng-meng, DONG Jing, SUN Qi, HUANG Mai-ling, DING Ze-yu, SHI Yu-ting, JIA Hong-yan, DU Bo-ping, WEI Rong-rong, XING Ai-ying, ZHANG Zong-de, PAN Li-ping. Diagnostic performance of differentially expressed miRNA identified by gene chip in discriminating tuberculous meningitis from viral meningitis [J]. Chinese Journal of Antituberculosis, 2022, 44(3): 264-272.
[9]	LI Duo, LYU Yan, LYU Ping-xin. Study of MRI characteristics of spinal tuberculous meningitis and the change after anti-tuberculosis treatment [J]. Chinese Journal of Antituberculosis, 2022, 44(3): 258-263.
[10]	WANG Xin, Maierdan·Abulai, LIN Yi-hong, ZHANG Wen-tao. Changes of CD cells in peripheral blood of tuberculous meningitis patients with negative HIV antibody before and after treatment [J]. Chinese Journal of Antituberculosis, 2022, 44(1): 78-82.
[11]	Li Shuyan,Liu Guoli,Wu Hailiang,Zhan Yunfei,Yang Xiaoguang. Clinical analysis on 13 cases with multiple intracranial tuberculomas [J]. Chinese Journal of Antituberculosis, 2011, 33(5): 280-283.
[12]	ZHU Min, LIU Ya-Dong, YIN Liang-Sheng. Diagnositic value of ADA、ADA2、IL-12、IFN-γ in Tuberculous Meningitis [J]. Chinese Journal of Antituberculosis, 2010, 32(11): 744-746.
[13]	. [J]. Chinese Journal of Antituberculosis, 2010, 32(8): 57-59.
[14]	Han Lijun,Yan Shiming,Qin Guixiang,Sun Li,Feng Lina. Study on the diagnostic value of four detection methods of Mycobacterium tuberculosis in cerebrospinal fluid for tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2010, 32(5): 50-52.